查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1669509

2025 年综合代谢组 (CMP) 测试全球市场报告

Comprehensive Metabolic Panel (CMP) Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

综合代谢组（CMP）测试市场规模预计将在未来几年强劲成长。到 2029 年，这一数字将成长至 260.2 亿美元，复合年增长率为 9.1%。预测期内的成长可归因于个人化和精准医疗、远端医疗服务中 CMP 测试的整合、全面健康检查的需求、健康和预防性医疗保健倡议的兴起以及不断发展的医疗保健政策和法规。预测期内的主要趋势包括持续监测和纵向追踪、适合远端医疗的报告格式、参考范围的标准化、可穿戴健康技术的整合以及对病患​​教育和参与的重视。

心血管疾病和糖尿病盛行率的预期成长预计将推动综合代谢组 (CMP) 测试市场的成长。影响心臟和血管的心血管疾病通常与动脉粥状硬化（动脉中脂肪沉积的堆积）有关。同时，以血糖值升高为特征的糖尿病可以透过综合METABOLIC INC.组（CMP）血液检查来识别。随着糖尿病和心血管疾病病例的增加，对包括 CMP 血液检测在内的诊断性血液检测的需求预计将飙升。例如，澳洲健康与福利研究所提供的2023年12月资料显示，经医生认证的心臟疾病（CHD）导致的死亡人数呈上升趋势，到2022年将达到14,900人。此外，2022年6月，国际糖尿病联盟报告称，全球糖尿病盛行率为10.5%，其中相当一部分（44.7%）患者仍未被诊断。因此，心血管疾病和糖尿病的盛行率不断上升是推动综合代谢组 (CMP) 测试市场发展的主要因素。

预计老年人口的成长将在未来几年推动综合代谢组 (CMP) 检测市场的扩张。 「老年人口」指的是老年人，一般指65岁以上的老年人。由于年龄较大，老年人通常需要更频繁地进行健康筛检，包括代谢组测试，以监测健康状况并解决与老龄化相关的问题。 CMP 测试对老年人来说至关重要，可以帮助检测肾臟疾病、荷尔蒙失衡和糖尿病等潜在疾病。例如，根据英国治理机构英国国会在2024年7月的预测，到2022年，英国65岁及以上人口将达到1,270万人（占总人口的19%），到2072年，这一数字预计将上升到2,210万人（占总人口的27%）。因此，老年人口的增加正在刺激CMP检测市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第 4 章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球综合代谢组 (CMP) 测试 PESTEL 分析（政治、社会、技术、环境、法律、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球综合代谢组 (CMP) 测试市场：成长率分析
  • 全球综合代谢组 (CMP) 检测市场表现：规模与成长，2019 年至 2024 年
  • 全球综合代谢组 (CMP) 检测市场预测：2024-2029 年、2034 年规模与成长
  • 全球综合代谢组 (CMP) 测试总目标市场 (TAM)

第六章 市场细分

  • 全球综合代谢组 (CMP) 检测市场：按疾病、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 肾臟疾病
  • 肝臟疾病
  • 糖尿病
  • 其他疾病
  • 全球综合代谢组 (CMP) 检测市场依检测类型、效能及预测，2019-2024 年、2024-2029 年、2034 年
  • 蛋白质
  • 电解质
  • 肾臟检查
  • 肝功能检查
  • 葡萄糖
  • 全球综合代谢组 (CMP) 检测市场（按最终用户、绩效和预测）2019-2024 年、2024-2029 年、2034 年
  • 研究所
  • 照护现场(PoC)
  • 全球综合代谢组 (CMP) 检测市场按肾臟疾病细分、类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 慢性肾臟病(CKD)
  • 急性肾损伤 (AKI)
  • 肾丝球肾炎
  • 全球综合代谢组 (CMP) 检测市场按肝病细分、类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 肝炎（病毒性和非病毒性）
  • 肝硬化
  • 脂肪肝
  • 全球综合代谢组 (CMP) 检测市场（按糖尿病类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 1 型糖尿病
  • 2 型糖尿病
  • 妊娠糖尿病
  • 全球综合代谢组 (CMP) 检测市场、其他疾病细分市场、类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 心血管疾病
  • 电解质失衡
  • 代谢紊乱
  • 胰臟疾病

第七章 区域和国家分析

  • 全球综合代谢组 (CMP) 检测市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球综合代谢组 (CMP) 检测市场：按国家/地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第 17 章 德国市场

第 18 章 法国市场

第 19 章：义大利市场

第 20 章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第 25 章：加拿大市场

第26章 南美洲市场

第 27 章：巴西市场

第28章 中东市场

第 29 章：非洲市场

第 30 章竞争格局与公司概况

  • 综合代谢组 (CMP) 检测市场：竞争格局
  • 综合代谢组 (CMP) 检测市场：公司简介
    • Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Mayo Clinic Overview, Products and Services, Strategy and Financial Analysis
    • Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • Mercy Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Mount Sinai Health System
  • Quest Diagnostics Incorporated
  • Sonic Healthcare Limited
  • Hologic Inc.
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • Werfen SA
  • DiaSorin SpA
  • Randox Laboratories Ltd.
  • ARUP Laboratories Inc.
  • Invitae Corporation
  • Abaxis Inc.
  • Metropolis Healthcare Limited
  • Clinical Reference Laboratory（CRL）
  • Centogene AG

第 32 章 全球市场竞争基准化分析与仪表板

第33章 重大併购

第 34 章 近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029 年综合代谢组 (CMP) 检测市场：提供新机会的国家
  • 2029 年综合代谢组 (CMP) 检测市场：细分市场将带来新机会
  • 2029 年综合代谢组 (CMP) 检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第 36 章 附录

简介目录
Product Code: r24818

A comprehensive metabolic panel (CMP) test is a blood analysis consisting of 14 distinct parameters that provide crucial insights into the body's chemical balance and metabolic processes. This test serves as a vital tool for evaluating nutritional levels, liver and kidney functionality, and aids in diagnosing, screening, and monitoring various health conditions.

The primary diseases and health conditions assessed through comprehensive metabolic panel (CMP) testing include kidney disease, liver disease, diabetes, and other metabolic disorders. Kidney disease is characterized by impaired kidney function, affecting its ability to effectively filter blood and perform essential functions. The test encompasses evaluations of proteins, electrolytes, kidney function, liver function, and glucose levels, conducted in both laboratory settings and point-of-care (PoC) environments.

The comprehensive metabolic panel (CMP) testing market research report is one of a series of new reports from The Business Research Company that provides comprehensive metabolic panel (CMP) testing market statistics, including comprehensive metabolic panel (CMP) testing industry global market size, regional shares, competitors with a comprehensive metabolic panel (CMP) testing market share, detailed comprehensive metabolic panel (CMP) testing market segments, market trends and opportunities, and any further data you may need to thrive in the comprehensive metabolic panel (CMP) testing industry. This comprehensive metabolic panel (CMP) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The comprehensive metabolic panel (CMP) testing market size has grown strongly in recent years. It will grow from $17.04 billion in 2024 to $18.39 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to a rise in chronic diseases, demand for holistic health assessments, healthcare system emphasis on preventive care, rise in lifestyle-related conditions, and patient-centric healthcare approach

The comprehensive metabolic panel (CMP) testing market size is expected to see strong growth in the next few years. It will grow to $26.02 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to personalized medicine and precision healthcare, integration of CMP testing in telehealth services, demand for comprehensive health screenings, rise in wellness and preventive health initiatives, and evolving healthcare policies and regulations. Major trends in the forecast period include continuous monitoring and longitudinal tracking, telemedicine-friendly reporting formats, standardization of reference ranges, integration of wearable health technology, and emphasis on patient education and engagement.

The anticipated rise in the prevalence of cardiovascular diseases and diabetes is expected to be a driving force behind the growth of the comprehensive metabolic panel (CMP) testing market. Cardiovascular diseases, which affect the heart and blood vessels, are often associated with atherosclerosis-the accumulation of fatty deposits within arteries. Concurrently, diabetes, characterized by elevated blood glucose levels, can be identified through comprehensive metabolic panel (CMP) blood tests. As cases of diabetes and cardiovascular diseases increase, the demand for diagnostic blood tests, including the CMP blood test, is likely to surge. For instance, data from December 2023 provided by the Australian Institute of Health and Welfare indicated a rising trend in doctor-certified fatalities attributed to coronary heart disease (CHD), reaching 14,900 in 2022. Additionally, in June 2022, the International Diabetes Federation reported a global diabetes prevalence of 10.5%, with a significant portion (44.7%) of individuals remaining undiagnosed. Consequently, the growing incidence of cardiovascular diseases and diabetes is a key driver propelling the comprehensive metabolic panel (CMP) testing market.

The growing geriatric population is expected to drive the expansion of the comprehensive metabolic panel (CMP) testing market in the coming years. The term "geriatric population" refers to individuals who are elderly, typically defined as those aged 65 or older. Due to their advanced age, older individuals generally require more frequent health screenings, including metabolic panel testing, to monitor their well-being and address age-related issues. CMP testing is essential for the elderly, helping to detect underlying conditions like kidney disease, hormonal imbalances, and diabetes. For instance, in July 2024, according to the UK Parliament, a UK-based governing body, 12.7 million people in the UK were aged 65 or older in 2022 (accounting for 19% of the population), and by 2072, this figure is projected to increase to 22.1 million, or 27% of the population. Thus, the rising geriatric population is fueling the growth of the CMP testing market.

The comprehensive metabolic panel (CMP) testing market is witnessing a significant trend of technological advancements, with major companies investing in innovative solutions to fortify their market positions. In April 2022, HealthifyMe, an Indian wellness and fitness services company, introduced HealthifyPro, a flagship fitness plan incorporating a metabolic panel based on a comprehensive blood test measuring over 80 different factors. HealthifyPro utilizes a biosensor system, a smart scale, health coaches, an AI assistant, and a metabolic panel to track users' health. The integration of glucose patterns, dietary habits, and exercise behaviors enables the creation of personalized health approaches for each user, showcasing the role of technology in advancing metabolic panel testing.

Strategic partnerships are a prominent approach adopted by major companies in the comprehensive metabolic panel (CMP) testing market. These partnerships aim to enhance production capabilities, streamline testing processes, and meet the increasing demand for CMP testing across various industries. In August 2022, Abbott Laboratories, a US-based healthcare company, collaborated with WW International Inc., a provider of weight loss and fitness services. The partnership focuses on assisting individuals with diabetes in better understanding and managing their health. By integrating WeightWatchers' diabetes-specific weight management program with Abbott's FreeStyle Libre offerings, the collaboration aims to provide a seamless mobile experience, offering valuable insights for individuals with diabetes to make informed dietary adjustments and improve blood sugar levels, ultimately empowering them to take control of their health.

In March 2023, Fluxery, a medical diagnostic company headquartered in the United States, completed the acquisition of particular personnel, assets, and licensed electrochemical biosensing technologies from InnaMed Inc. The financial details of the transaction remain undisclosed. This strategic acquisition by Fluxery significantly expands its detection capabilities, allowing for the analysis of clinical chemistry and small molecules in various domains, including human healthcare, equine care, and veterinary services for small animals. InnaMed Inc., a decentralized blood testing company in the US, specializes in electrochemical biosensor technology.

Major companies operating in the comprehensive metabolic panel (CMP) testing market include Abbott Laboratories Inc., Siemens Healthineers AG, Mayo Clinic, Laboratory Corporation of America Holdings, Mercy, Mount Sinai Health System, Quest Diagnostics Incorporated, Sonic Healthcare Limited, Hologic Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Werfen SA, DiaSorin S.p.A., Randox Laboratories Ltd., ARUP Laboratories Inc., Invitae Corporation, Abaxis Inc., Metropolis Healthcare Limited, Clinical Reference Laboratory (CRL), Centogene AG, Spectra Laboratories, Unipath Systems Ltd., Scion Lab Services LLC, Weldon Biotech Pvt Ltd., Corona Pathology,Ulta Lab Tests LLC, Any Lab Test Now, Applied InGENuity Diagnostics LLC, Walk-In Lab LLC

North America was the largest region in the comprehensive metabolic panel (CMP) testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the comprehensive metabolic panel (cmp) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the comprehensive metabolic panel (cmp) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The comprehensive metabolic panel (CMP) testing market includes revenues earned by entities by providing glucose tests, sodium tests, and albumin tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Comprehensive Metabolic Panel (CMP) Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on comprehensive metabolic panel (cmp) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for comprehensive metabolic panel (cmp) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The comprehensive metabolic panel (cmp) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Disease: Kidney Disease; Liver Disease; Diabetes; Other Diseases
  • 2) By Test Type: Proteins; Electrolytes; Kidney Tests; Liver Functional Tests; Glucose
  • 3) By End User: Laboratories; Point Of Care (PoC)
  • Subsegments:
  • 1) By Kidney Disease: Chronic Kidney Disease (CKD); Acute Kidney Injury (AKI); Glomerulonephritis
  • 2) By Liver Disease: Hepatitis (Viral And Non-Viral); Cirrhosis; Fatty Liver Disease
  • 3) By Diabetes: Type 1 Diabetes; Type 2 Diabetes; Gestational Diabetes
  • 4) By Other Diseases: Cardiovascular Diseases; Electrolyte Imbalances; Metabolic Disorders; Pancreatic Diseases
  • Companies Mentioned: Abbott Laboratories Inc.; Siemens Healthineers AG; Mayo Clinic; Laboratory Corporation of America Holdings; Mercy
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Comprehensive Metabolic Panel (CMP) Testing Market Characteristics

3. Comprehensive Metabolic Panel (CMP) Testing Market Trends And Strategies

4. Comprehensive Metabolic Panel (CMP) Testing Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Comprehensive Metabolic Panel (CMP) Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Comprehensive Metabolic Panel (CMP) Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Comprehensive Metabolic Panel (CMP) Testing Market Growth Rate Analysis
  • 5.4. Global Comprehensive Metabolic Panel (CMP) Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Comprehensive Metabolic Panel (CMP) Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Comprehensive Metabolic Panel (CMP) Testing Total Addressable Market (TAM)

6. Comprehensive Metabolic Panel (CMP) Testing Market Segmentation

  • 6.1. Global Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Kidney Disease
  • Liver Disease
  • Diabetes
  • Other Diseases
  • 6.2. Global Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Proteins
  • Electrolytes
  • Kidney Tests
  • Liver Functional Tests
  • Glucose
  • 6.3. Global Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratories
  • Point Of Care (PoC)
  • 6.4. Global Comprehensive Metabolic Panel (CMP) Testing Market, Sub-Segmentation Of Kidney Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chronic Kidney Disease (CKD)
  • Acute Kidney Injury (AKI)
  • Glomerulonephritis
  • 6.5. Global Comprehensive Metabolic Panel (CMP) Testing Market, Sub-Segmentation Of Liver Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hepatitis (Viral And Non-Viral)
  • Cirrhosis
  • Fatty Liver Disease
  • 6.6. Global Comprehensive Metabolic Panel (CMP) Testing Market, Sub-Segmentation Of Diabetes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes
  • 6.7. Global Comprehensive Metabolic Panel (CMP) Testing Market, Sub-Segmentation Of Other Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiovascular Diseases
  • Electrolyte Imbalances
  • Metabolic Disorders
  • Pancreatic Diseases

7. Comprehensive Metabolic Panel (CMP) Testing Market Regional And Country Analysis

  • 7.1. Global Comprehensive Metabolic Panel (CMP) Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Comprehensive Metabolic Panel (CMP) Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Comprehensive Metabolic Panel (CMP) Testing Market

  • 8.1. Asia-Pacific Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Comprehensive Metabolic Panel (CMP) Testing Market

  • 9.1. China Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 9.2. China Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Comprehensive Metabolic Panel (CMP) Testing Market

  • 10.1. India Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Comprehensive Metabolic Panel (CMP) Testing Market

  • 11.1. Japan Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 11.2. Japan Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Comprehensive Metabolic Panel (CMP) Testing Market

  • 12.1. Australia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Comprehensive Metabolic Panel (CMP) Testing Market

  • 13.1. Indonesia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Comprehensive Metabolic Panel (CMP) Testing Market

  • 14.1. South Korea Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 14.2. South Korea Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Comprehensive Metabolic Panel (CMP) Testing Market

  • 15.1. Western Europe Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 15.2. Western Europe Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Comprehensive Metabolic Panel (CMP) Testing Market

  • 16.1. UK Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Comprehensive Metabolic Panel (CMP) Testing Market

  • 17.1. Germany Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Comprehensive Metabolic Panel (CMP) Testing Market

  • 18.1. France Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Comprehensive Metabolic Panel (CMP) Testing Market

  • 19.1. Italy Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Comprehensive Metabolic Panel (CMP) Testing Market

  • 20.1. Spain Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Comprehensive Metabolic Panel (CMP) Testing Market

  • 21.1. Eastern Europe Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 21.2. Eastern Europe Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Comprehensive Metabolic Panel (CMP) Testing Market

  • 22.1. Russia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Comprehensive Metabolic Panel (CMP) Testing Market

  • 23.1. North America Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 23.2. North America Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Comprehensive Metabolic Panel (CMP) Testing Market

  • 24.1. USA Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 24.2. USA Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Comprehensive Metabolic Panel (CMP) Testing Market

  • 25.1. Canada Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 25.2. Canada Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Comprehensive Metabolic Panel (CMP) Testing Market

  • 26.1. South America Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 26.2. South America Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Comprehensive Metabolic Panel (CMP) Testing Market

  • 27.1. Brazil Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Comprehensive Metabolic Panel (CMP) Testing Market

  • 28.1. Middle East Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 28.2. Middle East Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Comprehensive Metabolic Panel (CMP) Testing Market

  • 29.1. Africa Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 29.2. Africa Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Comprehensive Metabolic Panel (CMP) Testing Market Competitive Landscape And Company Profiles

  • 30.1. Comprehensive Metabolic Panel (CMP) Testing Market Competitive Landscape
  • 30.2. Comprehensive Metabolic Panel (CMP) Testing Market Company Profiles
    • 30.2.1. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Mayo Clinic Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Mercy Overview, Products and Services, Strategy and Financial Analysis

31. Comprehensive Metabolic Panel (CMP) Testing Market Other Major And Innovative Companies

  • 31.1. Mount Sinai Health System
  • 31.2. Quest Diagnostics Incorporated
  • 31.3. Sonic Healthcare Limited
  • 31.4. Hologic Inc.
  • 31.5. Beckman Coulter Inc.
  • 31.6. Bio-Rad Laboratories Inc.
  • 31.7. Werfen SA
  • 31.8. DiaSorin S.p.A.
  • 31.9. Randox Laboratories Ltd.
  • 31.10. ARUP Laboratories Inc.
  • 31.11. Invitae Corporation
  • 31.12. Abaxis Inc.
  • 31.13. Metropolis Healthcare Limited
  • 31.14. Clinical Reference Laboratory (CRL)
  • 31.15. Centogene AG

32. Global Comprehensive Metabolic Panel (CMP) Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Comprehensive Metabolic Panel (CMP) Testing Market

34. Recent Developments In The Comprehensive Metabolic Panel (CMP) Testing Market

35. Comprehensive Metabolic Panel (CMP) Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Comprehensive Metabolic Panel (CMP) Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Comprehensive Metabolic Panel (CMP) Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Comprehensive Metabolic Panel (CMP) Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer